Functional effects of endogenous bradykinin in congestive heart failure.
about
New competition in the realm of renin-angiotensin axis inhibition; the angiotensin II receptor antagonists in congestive heart failure.A Single-Center, Open-Label, Randomized, Parallel-Group Study Assessing the Differences Between an Angiotensin II Receptor Antagonist and an Angiotensin-Converting Enzyme Inhibitor in Hypertensive Patients with Congestive Heart Failure: The ResearchDoes the kinin system mediate in cardiovascular abnormalities? An overview.Interaction between cyclooxygenase and the renin-angiotensin-aldosterone system: rationale and clinical relevance.Endothelin-converting enzyme inhibitors for the treatment of subarachnoid hemorrhage-induced vasospasm.Endothelial effects of antihypertensive treatment: focus on irbesartanThe kinin system in hypertensive pathophysiology.Different cross-talk sites between the renin-angiotensin and the kallikrein-kinin systems.New medications for heart failure.Vascular endothelial dysfunction in Duchenne muscular dystrophy is restored by bradykinin through upregulation of eNOS and nNOS.Bradykinin restores left ventricular function, sarcomeric protein phosphorylation, and e/nNOS levels in dogs with Duchenne muscular dystrophy cardiomyopathy.Alterations of endothelium-dependent and -independent regulation of coronary blood flow during heart failure.Altered frequency of a promoter polymorphism of the kinin B2 receptor gene in hypertensive African-Americans.Impaired bradykinin response to ischaemia and exercise in patients with mild congestive heart failure during angiotensin-converting enzyme treatment. Relationships with endothelial function, coagulation and inflammation.Angiotensin Receptor-Neprilysin Inhibition.Angiotensin-converting enzyme inhibitors reduce mortality compared to angiotensin receptor blockers: Systematic review and meta-analysis.Cellular basis of angiotensin-(1-7)-induced augmentation of left ventricular functional performance in heart failure.
P2860
Q31989723-B13F20AC-9A3D-48DD-A48E-EF39073EB641Q33738913-DEB6E011-8CF4-46C8-A6DE-B0CF9AA6FBB5Q35556530-10B98E08-C76E-4824-A871-3D7CA606E3A9Q35580134-D7A0AC2B-BA7B-463D-9226-EA7361320A51Q36681471-70F6DB5E-53A7-4EFE-A50E-24D7574B0B7FQ36766914-0CC22093-6398-4741-8661-E9D8FA2E7E85Q38004868-ECF83AAF-7C2E-4E43-9893-CAC80D95CB1BQ38079544-9381CA37-2AA2-4FCB-83A2-673C4BAADDB7Q38546656-8AFC5E57-DA67-4ABD-9F69-3F51996286DDQ41844106-64D40A95-2245-4C91-9C47-8BA03DBC24CEQ42647177-6C394AA8-FEE7-42E8-A4E8-B8CC21C9BA82Q43826627-7B2D27E7-60F4-45D6-BB2B-422A93E37A48Q46477408-7873ABB5-E959-41F6-ADD5-952493550BDBQ46569734-81D5E799-942A-4F40-BC96-B0776F1066F5Q46770238-A977860F-CF6A-4E8D-9236-9D14B676F7BCQ50237679-D64CE383-3AC9-47DC-889D-EE4FE4A5D429Q51186140-DD9ADB14-59BA-44E3-B19B-A9951A3AC26F
P2860
Functional effects of endogenous bradykinin in congestive heart failure.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Functional effects of endogenous bradykinin in congestive heart failure.
@en
Functional effects of endogenous bradykinin in congestive heart failure.
@nl
type
label
Functional effects of endogenous bradykinin in congestive heart failure.
@en
Functional effects of endogenous bradykinin in congestive heart failure.
@nl
prefLabel
Functional effects of endogenous bradykinin in congestive heart failure.
@en
Functional effects of endogenous bradykinin in congestive heart failure.
@nl
P2093
P1476
Functional effects of endogenous bradykinin in congestive heart failure.
@en
P2093
P304
P356
10.1016/S0735-1097(98)00159-4
P407
P577
1998-06-01T00:00:00Z